Nov 19
2026 will be defined by uncertainty — geopolitical instability, volatile global markets, and shifting health policies will influence every choice pharma companies make. From clinical trial planning to pipeline priorities, leaders will increasingly weigh innovation against risk, trying to preserve momentum while navigating an unpredictable global landscape.
Read the full article featuring Allison Cuff Shimooka from Clinical Leader here.
Related Blog Posts
Trendspotting: Embracing AI, DEI Changes, Restrategizing Research Sites
To kick off 2026, we spoke with industry experts and leaders in the Clinical Research News community about what they expect and look forward to in the new year. More than ever before, artificial intelligence took center stage. Read the full article featuring Allison Cuff Shimooka from Clinical Research News here.
Trendspotting: Artificial Intelligence, Impact of Global Policies, Data Harmonization
To kick off 2026, we spoke with industry experts and leaders in the Bio-IT World community about what they expect and look forward to in the new year. Read the full article featuring Allison Cuff Shimooka from Bio-It World here.
Working together to innovate on pragmatic clinical trials, with Rob DiCicco
Process innovation in the pharmaceutical industry is never easy, but its best chance of success comes when companies come together to work on big problems – especially when they bring in regulators and other stakeholders. Listen to the full podcast featuring Rob DiCicco by PharmaPhorum here.